Kangtai Bio: Convertible bonds see minor conversion activity

Shenzhen Kangtai Biological Products (SZSE:300601) announced that a small number of its "Kangtai Convertible 2" bonds were converted to shares in the first quarter of 2025. A total of 30 bonds, with a face value of CNY3,000, were converted into 150 shares of Kangtai Bio stock. As of March 31, 2025, the company has CNY1,999,014,600 remaining in outstanding convertible bonds, represented by 19,990,146 bonds. The conversion has a negligible impact on the overall share structure, with limited sales shares increasing to 79.31% of the total share capital. The latest conversion price is CNY15.82 per share. The company urges investors to refer to the full prospectus for complete details regarding the convertible bonds.